|apersy|

Value | Commercial | Access

Apersy provide flexible support to bring the commercial point of view to your development programme

Extensive experience, unique expertise

Seeing pricing and market access from all sides: experience working for different stakeholders

  • CROs
  • Investment management
  • NGOs/think tanks
  • Big pharma
  • Biotech
  • Start-ups & techtransfer

However novel your product or particular your situation, weird and wonderful is our bread and butter.

  • Digital medical devices / healthcare AI
  • Connected diagnostics
  • Microbiome products
  • Combination products
  • Advance therapies
  • Orphan drugs

Focus expertise on European markets

Healthcare systems, payers and insurance, reimbursement processes and HTA requirements, agencies, …

Collaborating differently

Being part of your team, intermediary, mentor, expert;

Finding the perfect development experts and partners for your needs;

Network within the healthcare and product development space.

Henrike Granzow, MSc


Market Access, pricing and reimbursement expert, Health Economist, mentor and trainer for health tech innovation, emerging & disruptive technologies.

For over 13 years I have been working within Life Science strategy consultancies, Biotech & MedTech investment management, clinical research organisations and health policy. My working approach focuses on value creation & takes a holistic view on asset & evidence strategy .

Special topics: Digital healthcare solutions, product strategy, multi-indication launches, orphan disease, ATMPs, due diligence, forecasting and portfolio advisory, diagnostics 

Working with Apersy

Co-creation

Your science meets commercial expertise

Intermediary

Connections, management and partnerships

Empowerment

Frameworks, thought processing and training that foster understanding